Investment Centers of America’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-9,003
Closed -$692K 332
2017
Q3
$692K Buy
9,003
+1,295
+17% +$97.8K 0.05% 284
2017
Q2
$579K Sell
7,708
-817
-10% -$57.9K 0.04% 323
2017
Q1
$566K Buy
8,525
+258
+3% +$17.2K 0.04% 343
2016
Q4
$539K Buy
8,267
+208
+3% +$13.5K 0.05% 320
2016
Q3
$575K Buy
8,059
+94
+1% +$6.85K 0.06% 269
2016
Q2
$591K Buy
7,965
+1,691
+27% +$117K 0.07% 251
2016
Q1
$406K Buy
6,274
+864
+16% +$58.8K 0.05% 300
2015
Q4
$418K Buy
+5,410
New +$430K 0.05% 281
2015
Q2
Sell
-2,586
Closed -$226K 470
2015
Q1
$226K Buy
+2,586
New +$229K 0.03% 388

Other funds holding NVS

Investment Centers of America's NVS Position: Q4 2017 in Review

Investment Centers of America sold out of Novartis (NVS) in Q4 2017, closing a stake of 9,003 shares — an estimated $692K sold.

Investment Centers of America first reported a position in NVS in Q1 2015 and held it in 9 quarters. The position peaked at $692K in Q3 2017. 1,007 funds tracked by Wall St. Rank hold NVS as of Q4 2017.

  • Investment Centers of America reported no remaining Novartis position as of Q4 2017 after selling out during the quarter.
  • Investment Centers of America sold 9,003 Novartis shares in Q4 2017, an estimated $692K.
  • Investment Centers of America first reported a position in Novartis in Q1 2015 and held it in 9 quarters.
  • Investment Centers of America's Novartis position peaked at $692K in Q3 2017.
  • 1,007 funds tracked by Wall St. Rank held Novartis as of Q4 2017.

Based on Investment Centers of America's 13F filing for Q4 2017, filed 14 Feb 2018.